ZIJING INTL FIN (08340) plans to conduct a stock consolidation using a "10 for 1" basis.
Cercis International Finance (08340) announced that the board of directors recommends a capital reduction of every 10 shares of the company's share capital, with a par value of 0.10 per share...
ZIJING INTL FIN (08340) announces that the Board of Directors recommends consolidating the existing issued and unissued shares of the company with a par value of HK$0.10 per share for every 10 shares into consolidated shares with a par value of HK$1.00 per share.
Following the consolidation of shares, a reduction of share capital will be implemented. As a result, any fractional consolidated shares in the company's issued share capital arising from the consolidation shall be cancelled. The issued share capital of the company will be reduced by cancelling the paid-up capital of HK$0.99 for each issued consolidated share, reducing the par value of each issued consolidated share from HK$1.00 to HK$0.01.
After the reduction of share capital takes effect, the legal but unissued consolidated shares with a par value of HK$1.00 per share will be split into 100 shares with a par value of HK$0.01 per share. The new shares will have equal rights in all respects according to the company's articles of association and rules.
As of the date of this announcement, the existing shares are traded on the Stock Exchange of Hong Kong in units of 20,000 shares per trade. After the consolidation of shares takes effect, the trading unit on the Stock Exchange is proposed to be changed from 20,000 existing shares to 5,000 consolidated shares.
Related Articles

ICONCULTURE(08500): Li Zhiying resigns as executive director

BRII-B(02137) signs intellectual property license and technology transfer agreement with Joincare Pharmaceutical Group Industry.

BOSS ZHIPIN-W (02076): The sale of shares will be traded on the Hong Kong Stock Exchange on July 4th.
ICONCULTURE(08500): Li Zhiying resigns as executive director

BRII-B(02137) signs intellectual property license and technology transfer agreement with Joincare Pharmaceutical Group Industry.

BOSS ZHIPIN-W (02076): The sale of shares will be traded on the Hong Kong Stock Exchange on July 4th.
